Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

The Study of Biodistribution and Dosimetry of 99mTc-Glycopeptide(99mTc-GP) in Patients With Breast Cancer

This study is currently recruiting participants. (see Contacts and Locations)
Verified July 2014 by SeeCure LLC
Sponsor:
Information provided by (Responsible Party):
SeeCure LLC
ClinicalTrials.gov Identifier:
NCT01159405
First received: July 8, 2010
Last updated: July 29, 2014
Last verified: July 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: April 2015
  Estimated Primary Completion Date: March 2015 (Final data collection date for primary outcome measure)